Compassionate use of psychedelics
Greif, A., & Šurkala, M. | Medicine, Health Care, and Philosophy | 23 September 2020
Phytochemical, Cytotoxicity, Antioxidant and Anti-Inflammatory Effects of Psilocybe Natalensis Magic Mushroom
Nkadimeng, S. M., Nabatanzi, A., Steinmann, C. M., & Eloff, J. N. | Plants | 31 August 2020
Plasma psilocin critically determines behavioral and neurobiological effects of psilocybin
Madsen, M. K., & Knudsen, G. M. | Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology | 25 August 2020
P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlap
Smigielski, L., Kometer, M., Scheidegger, M., Stress, C., Preller, K. H., Koenig, T., & Vollenweider, F. X. | Human brain mapping | 21 Aug 2020
Psychedelic science in post-COVID-19 psychiatry
Kelly, J. R., Crockett, M. T., Alexander, L., Haran, M., Baker, A., Burke, L., & O’Keane, V. | Irish journal of psychological medicine | 19 Aug 2020
Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies
Breeksema, J. J., Niemeijer, A. R., Krediet, E., Vermetten, E., & Schoevers, R. A | CNS drugs | 17 August 2020
[Psychedelics for existential distress in terminally ill patients]
Schimmel, N., Breeksema, J. J., Veraart, J. K. E., van den Brink, W., & Schoevers, R. A. | Tijdschrift Voor Psychiatrie | 1 August 2020
Microdosing with psychedelics: what do we know?
Kuypers, K. P. C. | Tijdschrift Voor Psychiatrie | 1 Augustus 2020
Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms
Morita, I., Oyama, H., Kiguchi, Y., Oguri, A., Fujimoto, N., Takeuchi, A., ... & Kobayashi, N. | Journal of Pharmaceutical and Biomedical Analysis | 21 July 2020
Perceived harm, motivations for use and subjective experiences of recreational psychedelic ‘magic’ mushroom use
Roberts, C. A., Osborne-Miller, I., Cole, J., Gage, S. H., & Christiansen, P. | Journal of Psychopharmacology| 17 July 2020
Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains
Varley, T. F., Carhart-Harris, R., Roseman, L., Menon, D. K., & Stamatakis, E. A. | NeuroImage | 30 June 2020
Psilocybin occasioned mystical-type experiences
James, E., Robertshaw, T. L., Hoskins, M., & Sessa, B. | Human Psychopharmacology: Clinical and Experimental | 23 June 2020
Spotlight commentary: REBUS and the anarchic brain
Carhart-Harris, R. L., & Friston, K. J. | Pharmacological reviews | 12 June 2020
A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy
Luoma, J. B., Chwyl, C., Bathje, G. J., Davis, A. K., & Lancelotta, R. | Journal Of Psychoactive Drugs | 12 June 2020
Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland
Kangaslampi, S., Hausen, A., & Rauteenmaa, T. | Journal of Psychoactive Drugs | 8 June 2020
Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan
Carbonaro, T. M., Johnson, M. W., & Griffiths, R. R | Psychopharmacology | 5 June 2020
Psilocybin: from ancient magic to modern medicine
Nichols, D. E. | The Journal of Antibiotics | 12 May 2020
Psychedelic treatment of functional neurological disorder: a systematic review
Butler, M., Seynaeve, M., Nicholson, T. R., Pick, S., Kanaan, R. A., Lees, A., ... & Rucker, J. | Therapeutic Advances in Psychopharmacology | 11 May 2020
Psilocybin and LSD Have No Long-Lasting Effects in an Animal Model of Alcohol Relapse
Meinhardt, M. W., Güngör, C., Skorodumov, I., Mertens, L. J., & Spanagel, R. | Neuropsychopharmacology | 5 May 2020
Chronic pain and psychedelics: a review and proposed mechanism of action
Castellanos, J. P., Woolley, C., Bruno, K. A., Zeidan, F., Halberstadt, A., & Furnish, T. | Regional Anesthesia & Pain Medicine | 4 May 2020
The Viability of Microdosing Psychedelics as a Strategy to Enhance Cognition and Well-being – An Early Review
Bornemann, J. | Journal of Psychoactive Drugs | 2 May 2020
Psychedelics and Psychedelic-Assisted Psychotherapy
Reiff, C. M., Richman, E. E., Nemeroff, C. B., Carpenter, L. L., Widge, A. S., Rodriguez, C. I. | American Journal of Psychiatry | 1 May 2020
Dynamic coupling of whole-brain neuronal and neurotransmitter systems
Kringelbach, M. L., Cruzat, J., Cabral, J., Knudsen, G. M., Carhart-Harris, R., Whybrow, P. C., ... & Deco, G. | Proceedings of the National Academy of Sciences | 13 April 2020
Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin
Dahmane, E., Hutson, P. R., & Gobburu, J. V. | Clinical Pharmacology in Drug Development | 06 April 2020
Psychedelic Psychiatry’s Brave New World
Nutt, D., Erritzoe, D., & Carhart-Harris, R. | Cell | 2 April 2020